Gastric Plexiform Fibromyxoma: A Narrative Review of a Rare Mesenchymal Tumor
Clicks: 4
ID: 311585
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.9
/100
4 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #30 of 254 articles by views in Yemen Journal of Medicine
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 254 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Gastric plexiform fibromyxoma (GPF) is a rare mesenchymal tumor that primarily affects the stomach, and to date, only about 170 cases have been reported. It is benign in nature with a favorable long-term prognosis. GPF mimics many disease entities, including the malignant ones, and the proper diagnosis differentiation requires a battery of investigations, including imaging, histopathology, immunochemistry, and molecular genetics studies. Management is generally surgical. This article is drafted to revisit various aspects of GPF to enhance the level of awareness in healthcare providers.
| Reference Key |
salati2025gastric
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sajad Ahmad Salati, Ajaz Ahmad Rather |
| Journal | Yemen Journal of Medicine |
| Year | 2025 |
| DOI |
10.63475/yjm.v4i3.0216
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.